The impact of weekly semaglutide, a glucagon-like peptide-1 agonist, on kidney outcomes in adults with type 2 diabetes mellitus

The impact of weekly semaglutide, a glucagon-like peptide-1 agonist, on kidney outcomes in adults with type 2 diabetes mellitus

Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder associated with kidney complications. This study aims to investigate the effects of weekly subcutaneous semaglutide, a GLP-1 agonist, on kidney outcomes. Methods: This retrospective cohort study was conducted in nephrology a...

Full description

Bibliographic Details
Main Authors: Ahmad A Algarni, Fahad S Alqarni, Hanin A Shalaby
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
albuminuria
chronic kidney disease
egfr
glucagon-like peptide-1 receptor agonists
semaglutide
type 2 diabetes
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2024;volume=13;issue=2;spage=532;epage=536;aulast=Algarni

Similar Items

Similar Items